Tiziana Life Sciences is a buy due to its platform optionality and upcoming catalysts that outweigh its dilution risk and ...

Bubbles pop when technology fails to monetize. The companies pushing AI forward are the most profitable businesses in history ...

Mettler-Toledo Intl has a lower P/E than the aggregate P/E of 50.67 of the Life Sciences Tools & Services industry. Ideally, ...

Commvault Systems, Inc. is upgraded to buy with ample liquidity, share buybacks, and a recent business acquisition. Learn ...

Powered by DataVault AI’s High-Performance Computing & Information Exchange, Data Monetization for Traditional and Compound Pharmacies is Set to Become a Reality in the $639 Billion Prescription ...

Research and Development Expenses -- $9.6 million in the third quarter of 2025, down from $12.3 million in Q3 2024, due to ...

Both companies were back at it on Tuesday, announcing deals that once again added billions in value to public companies.

The AI buildout has lifted the sales and stocks of companies across various sectors, but none have seen their valuations rise ...

Learn how depth of market (DOM) data reflects supply and demand in stocks, helping traders predict price directions and ...

Return to shareholders -- $1.4 billion was returned to shareholders as of fiscal Q3 2025 through dividends and share repurchases. Anticipated step-up in expenses -- Research and development, as well ...

When it comes to the narrative scaffolding undergirding the financial publication industry, the jig could be up — at least ...

BlackRock, with $11 trillion in assets under management, is often referred to as the third most important economic entity on ...